{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:53:41Z","timestamp":1775822021565,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11728-8","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T09:59:18Z","timestamp":1775815158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Melatonin enhances the antitumor and immunomodulatory effects of Bacillus Calmette-Gu\u00e9rin immunotherapy in a murine bladder cancer model"],"prefix":"10.1007","volume":"53","author":[{"given":"Iman","family":"Menbari Oskouie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Khatami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gholamreza","family":"Mesbah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila Zareian","family":"Baghdadabad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nooshin","family":"Eidinezhad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahil","family":"Mashhadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parisa","family":"Zahmatkesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramin","family":"Heshamt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parsa","family":"Nikoofar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mohammad Kazem","family":"Aghamir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"issue":"3","key":"11728_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 74(3):229\u2013263","journal-title":"Cancer J Clin"},{"issue":"3","key":"11728_CR2","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","volume":"71","author":"M Babjuk","year":"2017","unstructured":"Babjuk M, B\u00f6hle A, Burger M, Capoun O, Cohen D, Comp\u00e9rat EM et al (2017) EAU guidelines on non\u2013muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71(3):447\u2013461","journal-title":"Eur Urol"},{"issue":"6","key":"11728_CR3","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.eururo.2012.08.055","volume":"62","author":"DR Yates","year":"2012","unstructured":"Yates DR, Brausi MA, Catto JW, Dalbagni G, Roupr\u00eat M, Shariat SF et al (2012) Treatment options available for bacillus Calmette-Gu\u00e9rin failure in non\u2013muscle-invasive bladder cancer. Eur Urol 62(6):1088\u20131096","journal-title":"Eur Urol"},{"issue":"5","key":"11728_CR4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1586\/14737140.2015.1015419","volume":"15","author":"Y Wu","year":"2015","unstructured":"Wu Y, Enting D, Rudman S, Chowdhury S (2015) Immunotherapy for urothelial cancer: from BCG to checkpoint inhibitors and beyond. Expert Rev Anticancer Ther 15(5):509\u2013523","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"11728_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1586\/14737140.2015.961430","volume":"15","author":"Y Wang","year":"2015","unstructured":"Wang Y, Yang M, Yu Q, Yu L, Shao S, Wang X (2015) Recombinant bacillus Calmette-Gu\u00e9rin in urothelial bladder cancer immunotherapy: current strategies. Expert Rev Anticancer Ther 15(1):85\u201393","journal-title":"Expert Rev Anticancer Ther"},{"issue":"2","key":"11728_CR6","first-page":"104","volume":"6","author":"R Mohammadi Farsani","year":"2024","unstructured":"Mohammadi Farsani R, Golmohammadi P, Pakdel A, Khajavi A, Sol Cabrera V, Mohammadi A (2024) Effects of Opium Consumption Regarding Age and Body Mass Index on Bladder Cancer\u2019s Grade and Stage. Translational Res Urol 6(2):104\u2013109","journal-title":"Translational Res Urol"},{"issue":"4","key":"11728_CR7","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/sj.bjc.6602026","volume":"91","author":"R Bevers","year":"2004","unstructured":"Bevers R, Kurth K, Schamhart D (2004) Role of urothelial cells in BCG immunotherapy for superficial bladder cancer. Br J Cancer 91(4):607\u2013612","journal-title":"Br J Cancer"},{"issue":"1","key":"11728_CR8","doi-asserted-by":"publisher","first-page":"e00194","DOI":"10.1128\/cmr.00194-23","volume":"38","author":"GD Liatsos","year":"2025","unstructured":"Liatsos GD, Mariolis I, Hadziyannis E, Bamias A, Vassilopoulos D (2025) Review of BCG immunotherapy for bladder cancer. Clin Microbiol Rev 38(1):e00194\u2013e00123","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"11728_CR9","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3892\/etm.2012.634","volume":"4","author":"T Cai","year":"2012","unstructured":"Cai T, Nesi G, Mazzoli S, Meacci F, Tinacci G, Luciani LG et al (2012) Prediction of response to bacillus Calmette-Gu\u00e9rin treatment in non-muscle invasive bladder cancer patients through interleukin-6 and interleukin-10 ratio. Experimental therapeutic Med 4(3):459\u2013464","journal-title":"Experimental therapeutic Med"},{"issue":"5","key":"11728_CR10","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.eururo.2017.10.003","volume":"73","author":"AM Kamat","year":"2018","unstructured":"Kamat AM, Li R, O\u2019Donnell MA, Black PC, Roupret M, Catto JW et al (2018) Predicting response to intravesical bacillus Calmette-Gu\u00e9rin immunotherapy: are we there yet? A systematic review. Eur Urol 73(5):738\u2013748","journal-title":"Eur Urol"},{"issue":"5","key":"11728_CR11","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/j.juro.2010.06.147","volume":"184","author":"KG Nepple","year":"2010","unstructured":"Nepple KG, Lightfoot AJ, Rosevear HM, O\u2019Donnell MA, Lamm DL (2010) Bacillus calmette-gu\u00e9rin with or without interferon \u03b1-2b and megadose versus recommended daily allowance vitamins during induction and maintenance intravesical treatment of nonmuscle invasive bladder cancer. J Urol 184(5):1915\u20131919","journal-title":"J Urol"},{"issue":"7","key":"11728_CR12","first-page":"2747","volume":"32","author":"A Cutando","year":"2012","unstructured":"Cutando A, L\u00f3pez-Valverde A, Arias-Santiago S, De Vicente J, DE DIEGO RG (2012) Role of melatonin in cancer treatment. Anticancer Res 32(7):2747\u20132753","journal-title":"Anticancer Res"},{"issue":"10","key":"11728_CR13","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1096\/fj.10-154450","volume":"24","author":"F Luchetti","year":"2010","unstructured":"Luchetti F, Canonico B, Betti M, Arcangeletti M, Pilolli F, Piroddi M et al (2010) Melatonin signaling and cell protection function. FASEB J 24(10):3603\u20133624","journal-title":"FASEB J"},{"issue":"6","key":"11728_CR14","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1007\/s10571-023-01324-w","volume":"43","author":"SB Ahmad","year":"2023","unstructured":"Ahmad SB, Ali A, Bilal M, Rashid SM, Wani AB, Bhat RR et al (2023) Melatonin and health: insights of melatonin action, biological functions, and associated disorders. Cell Mol Neurobiol 43(6):2437\u20132458","journal-title":"Cell Mol Neurobiol"},{"issue":"3B","key":"11728_CR15","first-page":"2103","volume":"20","author":"P Lissoni","year":"2000","unstructured":"Lissoni P, Bolis S, Brivio F, Fumagalli L (2000) A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies. Anticancer Res 20(3B):2103\u20132105","journal-title":"Anticancer Res"},{"issue":"2","key":"11728_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0165-5728(95)00135-2","volume":"63","author":"R Konakchieva","year":"1995","unstructured":"Konakchieva R, Kyurkchiev S, Kehayov I, Taushanova P, Kanchev L (1995) Selective effect of methoxyindoles on the lymphocyte proliferation and melatonin binding to activated human lymphoid cells. J Neuroimmunol 63(2):125\u2013132","journal-title":"J Neuroimmunol"},{"issue":"2","key":"11728_CR17","doi-asserted-by":"publisher","first-page":"574","DOI":"10.4049\/jimmunol.159.2.574","volume":"159","author":"S Garcia-Mauri\u00f1o","year":"1997","unstructured":"Garcia-Mauri\u00f1o S, Gonzalez-Haba MG, Calvo JR, Rafii-El-Idrissi M, Sanchez-Margalet V, Goberna R et al (1997) Melatonin enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4\u2009+\u2009cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes. J Immunol 159(2):574\u2013581","journal-title":"J Immunol"},{"issue":"1","key":"11728_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000069464","volume":"16","author":"P Lissoni","year":"1998","unstructured":"Lissoni P, Rovelli F, Brivio F, Brivio O, Fumagalli L (1998) Circadian secretions of IL-2, IL-12, IL-6 and IL-10 in relation to the light\/dark rhythm of the pineal hormone melatonin in healthy humans. Nat Immun 16(1):1\u20135","journal-title":"Nat Immun"},{"issue":"20","key":"11728_CR19","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1016\/S0024-3205(99)00479-8","volume":"65","author":"S Garc\u00eda-Mauri\u00f1o","year":"1999","unstructured":"Garc\u00eda-Mauri\u00f1o S, Pozo D, Carrillo-Vico A, Calvo JR, Guerrero JM (1999) Melatonin activates Th1 lymphocytes by increasing IL-12 production. Life Sci 65(20):2143\u20132150","journal-title":"Life Sci"},{"issue":"1","key":"11728_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11010-017-3154-2","volume":"440","author":"R Pariente","year":"2018","unstructured":"Pariente R, Bejarano I, Rodr\u00edguez AB, Pariente JA, Espino J (2018) Melatonin increases the effect of 5-fluorouracil-based chemotherapy in human colorectal adenocarcinoma cells in vitro. Mol Cell Biochem 440(1):43\u201351","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"11728_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/tox.22674","volume":"34","author":"YC Yang","year":"2019","unstructured":"Yang YC, Chiou PC, Chen PC, Liu PY, Huang WC, Chao CC et al (2019) Melatonin reduces lung cancer stemness through inhibiting of PLC, ERK, p38, \u03b2-catenin, and Twist pathways. Environ Toxicol 34(2):203\u2013209","journal-title":"Environ Toxicol"},{"issue":"3","key":"11728_CR22","doi-asserted-by":"publisher","first-page":"e0150407","DOI":"10.1371\/journal.pone.0150407","volume":"11","author":"NN Goncalves","year":"2016","unstructured":"Goncalves NN, Colombo J, Lopes JR, Gelaleti GB, Moschetta MG, Sonehara NM et al (2016) Effect of melatonin in epithelial mesenchymal transition markers and invasive properties of breast cancer stem cells of canine and human cell lines. PLoS ONE 11(3):e0150407","journal-title":"PLoS ONE"},{"issue":"3","key":"11728_CR23","doi-asserted-by":"publisher","first-page":"254","DOI":"10.7150\/jca.10796","volume":"6","author":"PG Kup","year":"2015","unstructured":"Kup PG, Nieder C, Geinitz H, Henkenberens C, Besserer A, Oechsner M et al (2015) The prognostic value of irradiated lung volumes on the prediction of intra-\/post-operative mortality in patients after neoadjuvant radiochemotherapy for esophageal cancer. A retrospective multicenter study. J Cancer 6(3):254","journal-title":"J Cancer"},{"issue":"1","key":"11728_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1600-079X.2012.01026.x","volume":"54","author":"SY Shiu","year":"2013","unstructured":"Shiu SY, Leung WY, Tam CW, Liu VW, Yao KM (2013) Melatonin MT1 receptor-induced transcriptional up\u2010regulation of p27Kip1 in prostate cancer antiproliferation is mediated via inhibition of constitutively active nuclear factor kappa B (NF\u2010\u03baB): potential implications on prostate cancer chemoprevention and therapy. J Pineal Res 54(1):69\u201379","journal-title":"J Pineal Res"},{"issue":"24","key":"11728_CR25","doi-asserted-by":"publisher","first-page":"8649","DOI":"10.3390\/molecules27248649","volume":"27","author":"S-Y Hsiao","year":"2022","unstructured":"Hsiao S-Y, Tang C-H, Chen P-C, Lin T-H, Chao C-C (2022) Melatonin inhibits EMT in bladder cancer by targeting autophagy. Molecules 27(24):8649","journal-title":"Molecules"},{"issue":"3","key":"11728_CR26","doi-asserted-by":"publisher","first-page":"e12765","DOI":"10.1111\/jpi.12765","volume":"71","author":"J Wu","year":"2021","unstructured":"Wu J, Tan Z, Li H, Lin M, Jiang Y, Liang L et al (2021) Melatonin reduces proliferation and promotes apoptosis of bladder cancer cells by suppressing O-GlcNAcylation of cyclin\u2010dependent\u2010like kinase 5. J Pineal Res 71(3):e12765","journal-title":"J Pineal Res"},{"issue":"1","key":"11728_CR27","doi-asserted-by":"publisher","first-page":"e12536","DOI":"10.1111\/jpi.12536","volume":"66","author":"YT Chen","year":"2019","unstructured":"Chen YT, Yang CC, Shao PL, Huang CR, Yip HK (2019) Melatonin-mediated downregulation of ZNF746 suppresses bladder tumorigenesis mainly through inhibiting the AKT\u2010MMP\u20109 signaling pathway. J Pineal Res 66(1):e12536","journal-title":"J Pineal Res"},{"key":"11728_CR28","doi-asserted-by":"crossref","unstructured":"Ozdemir-Sanci T, Sanci A, Alimogullar\u0131 E, Karakoyunlu AN (2024) Effects of melatonin on different stages of bladder cancer survival. Bull Urooncology","DOI":"10.4274\/uob.galenos.2024.2024.10.1"},{"issue":"2","key":"11728_CR29","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.eururo.2015.08.037","volume":"69","author":"J Dobruch","year":"2016","unstructured":"Dobruch J, Daneshmand S, Fisch M, Lotan Y, Noon AP, Resnick MJ et al (2016) Gender and bladder cancer: a collaborative review of etiology, biology, and outcomes. Eur Urol 69(2):300\u2013310","journal-title":"Eur Urol"},{"issue":"5","key":"11728_CR30","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0090-4295(97)00067-8","volume":"49","author":"TT Bui","year":"1997","unstructured":"Bui TT, Schellhammer PF (1997) Additional bacillus Calmette-Guerin therapy for recurrent transitional cell carcinoma after an initial complete response. Urology 49(5):687\u2013691","journal-title":"Urology"},{"key":"11728_CR31","doi-asserted-by":"crossref","unstructured":"Stein JP, Skinner DG (2003)  Results with radical cystectomy for treating bladder cancer: a\u2019reference standard\u2019for high-grade, invasive bladder cancer. BJU Int 92:12\u201317","DOI":"10.1046\/j.1464-410X.2003.04274.x"},{"key":"11728_CR32","doi-asserted-by":"crossref","unstructured":"Gurunathan S, Qasim M, Kang M-H, Kim J-H (2021) Role and therapeutic potential of melatonin in various type of cancers. OncoTargets therapy. :2019\u20132052","DOI":"10.2147\/OTT.S298512"},{"issue":"1","key":"11728_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1034\/j.1600-079X.2003.00032.x","volume":"35","author":"P Lissoni","year":"2003","unstructured":"Lissoni P, Chilelli M, Villa S, Cerizza L, Tancini G (2003) Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial. J Pineal Res 35(1):12\u201315","journal-title":"J Pineal Res"},{"issue":"4","key":"11728_CR34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1177\/1534735411425484","volume":"11","author":"D Seely","year":"2012","unstructured":"Seely D, Wu P, Fritz H, Kennedy DA, Tsui T, Seely AJ et al (2012) Melatonin as adjuvant cancer care with and without chemotherapy: a systematic review and meta-analysis of randomized trials. Integr cancer Ther 11(4):293\u2013303","journal-title":"Integr cancer Ther"},{"issue":"4","key":"11728_CR35","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1600-079X.2005.00258.x","volume":"39","author":"E Mills","year":"2005","unstructured":"Mills E, Wu P, Seely D, Guyatt G (2005) Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis. J Pineal Res 39(4):360\u2013366","journal-title":"J Pineal Res"},{"key":"11728_CR36","first-page":"1","volume":"20","author":"MH Pourhanifeh","year":"2020","unstructured":"Pourhanifeh MH, Hosseinzadeh A, Juybari KB, Mehrzadi S (2020) Melatonin and urological cancers: a new therapeutic approach. Cancer Cell Int 20:1\u201311","journal-title":"Cancer Cell Int"},{"issue":"3","key":"11728_CR37","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrurol.2014.15","volume":"11","author":"G Redelman-Sidi","year":"2014","unstructured":"Redelman-Sidi G, Glickman MS, Bochner BH (2014) The mechanism of action of BCG therapy for bladder cancer\u2014a current perspective. Nat reviews Urol 11(3):153\u2013162","journal-title":"Nat reviews Urol"},{"issue":"1","key":"11728_CR38","first-page":"47","volume":"4","author":"S Karimaei","year":"2022","unstructured":"Karimaei S, Mashhadi R, Mirzaei A, Deyhimfar R, Shabestari AN, Rahimnia R (2022) Antibacterial and Antibiofilm Activities of Nisin from Lactococcus lactis and Alteration of the Bacteria-Induced Pro-Inflammatory Responses on kidney and bladder tumor Cell Lines. Translational Res Urol 4(1):47\u201353","journal-title":"Translational Res Urol"},{"issue":"1","key":"11728_CR39","first-page":"9634902","volume":"2018","author":"J Falke","year":"2018","unstructured":"Falke J, Parkkinen J, Vaahtera L, Hulsbergen-van de Kaa CA, Oosterwijk E, Witjes JA (2018) Curcumin as treatment for bladder cancer: A preclinical study of cyclodextrin-curcumin complex and BCG as intravesical treatment in an orthotopic bladder cancer rat model. Biomed Res Int 2018(1):9634902","journal-title":"Biomed Res Int"},{"issue":"7","key":"11728_CR40","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/S0959-8049(99)00057-X","volume":"35","author":"Y Gan","year":"1999","unstructured":"Gan Y, Zhang Y, Khoo H, Esuvaranathan K (1999) Antitumour immunity of bacillus Calmette\u2013Guerin and interferon alpha in murine bladder cancer. Eur J Cancer 35(7):1123\u20131129","journal-title":"Eur J Cancer"},{"key":"11728_CR41","doi-asserted-by":"crossref","unstructured":"Wang Y, Liu J, Yang X, Liu Y, Liu Y, Li Y et al (2018) Bacillus Calmette\u2013Gu\u00e9rin and anti-PD-L1 combination therapy boosts immune response against bladder cancer. OncoTargets therapy. :2891\u20132899","DOI":"10.2147\/OTT.S165840"},{"issue":"3","key":"11728_CR42","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.eururo.2008.01.013","volume":"54","author":"SJ Dovedi","year":"2008","unstructured":"Dovedi SJ, Kirby JA, Davies BR, Leung H, Kelly JD (2008) Celecoxib has potent antitumour effects as a single agent and in combination with BCG immunotherapy in a model of urothelial cell carcinoma. Eur Urol 54(3):621\u2013630","journal-title":"Eur Urol"},{"key":"11728_CR43","volume-title":"Lenalidomide augments the efficacy of bacillus Calmette-Guerin (BCG) immunotherapy in vivo","year":"2013","unstructured":"Lee EK, Tran J, Kamat AM (eds) (2013) Lenalidomide augments the efficacy of bacillus Calmette-Guerin (BCG) immunotherapy in vivo. Seminars and Original Investigations, Urologic Oncology"},{"issue":"8","key":"11728_CR44","first-page":"3107","volume":"15","author":"T-Y Hsieh","year":"2023","unstructured":"Hsieh T-Y, Sung W-W, Chang Y-C, Yu C-Y, Lu L-Y, Dong C et al (2023) Melatonin induces cell cycle arrest and suppresses tumor invasion in urinary bladder urothelial carcinoma. Aging 15(8):3107","journal-title":"Aging"},{"issue":"4","key":"11728_CR45","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3892\/ijo.2017.4097","volume":"51","author":"S Shrestha","year":"2017","unstructured":"Shrestha S, Zhu J, Wang Q, Du X, Liu F, Jiang J et al (2017) Melatonin potentiates the antitumor effect of curcumin by inhibiting IKK\u03b2\/NF-\u03baB\/COX-2 signaling pathway. Int J Oncol 51(4):1249\u20131260","journal-title":"Int J Oncol"},{"issue":"19","key":"11728_CR46","first-page":"4383","volume":"58","author":"S Cos","year":"1998","unstructured":"Cos S, Fern\u00e1ndez R, G\u00fc\u00e9zmes A, S\u00e1nchez-Barcel\u00f3 EJ (1998) Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res 58(19):4383\u20134390","journal-title":"Cancer Res"},{"issue":"6","key":"11728_CR47","doi-asserted-by":"publisher","first-page":"868","DOI":"10.3390\/ijms17060868","volume":"17","author":"P Pittayapruek","year":"2016","unstructured":"Pittayapruek P, Meephansan J, Prapapan O, Komine M, Ohtsuki M (2016) Role of matrix metalloproteinases in photoaging and photocarcinogenesis. Int J Mol Sci 17(6):868","journal-title":"Int J Mol Sci"},{"key":"11728_CR48","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.niox.2020.03.003","volume":"98","author":"YV Langle","year":"2020","unstructured":"Langle YV, Balarino NP, Belgorosky D, Morgado PDC, Sandes EO, Marino L et al (2020) Effect of nitric oxide inhibition in Bacillus Calmette-Guerin bladder cancer treatment. Nitric Oxide 98:50\u201359","journal-title":"Nitric Oxide"},{"issue":"1","key":"11728_CR49","doi-asserted-by":"publisher","first-page":"15648","DOI":"10.1038\/s41598-021-95157-6","volume":"11","author":"NM de Queiroz","year":"2021","unstructured":"de Queiroz NM, Marinho FV, de Araujo ACV, Fahel JS, Oliveira SC (2021) MyD88-dependent BCG immunotherapy reduces tumor and regulates tumor microenvironment in bladder cancer murine model. Sci Rep 11(1):15648","journal-title":"Sci Rep"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11728-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11728-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11728-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:03:48Z","timestamp":1775819028000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11728-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11728"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11728-8","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"20 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experimental procedures adhered to ARRIVE guidelines and were approved by the Institutional Animal Care and Use Committee of Tehran University of Medical Science (\n                      IR.TUMS.AEC.1402.083)\n                      .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"600"}}